Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 310691, 8 pages
http://dx.doi.org/10.1155/2013/310691
Research Article

Stat3 Upregulates Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4 Expression in Osteosarcoma Cells

1Department of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China

Received 26 September 2013; Revised 15 November 2013; Accepted 17 November 2013

Academic Editor: Brian Oliver

Copyright © 2013 Jia Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. C. Reich and L. Liu, “Tracking STAT nuclear traffic,” Nature Reviews Immunology, vol. 6, no. 8, pp. 602–612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Kirk, “Targeted therapies: STAT3 and EGFR target resistance,” Nature Reviews Clinical Oncology, vol. 9, p. 489, 2012. View at Publisher · View at Google Scholar
  3. A. Yoshimura, T. Naka, and M. Kubo, “SOCS proteins, cytokine signalling and immune regulation,” Nature Reviews Immunology, vol. 7, no. 6, pp. 454–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Hedvat, D. Huszar, A. Herrmann et al., “The JAK2 inhibitor AZD1480 potently blocks stat3 signaling and oncogenesis in solid tumors,” Cancer Cell, vol. 16, no. 6, pp. 487–497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kortylewski, H. Xin, M. Kujawski et al., “Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment,” Cancer Cell, vol. 15, no. 2, pp. 114–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Yu, D. Pardoll, and R. Jove, “STATs in cancer inflammation and immunity: a leading role for STAT3,” Nature Reviews Cancer, vol. 9, no. 11, pp. 798–809, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Lee, A. Herrmann, J.-H. Deng et al., “Persistently activated Stat3 maintains constitutive NF-κB activity in tumors,” Cancer Cell, vol. 15, no. 4, pp. 283–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Tu, L. Du, Q. M. Fan, Z. Tang, and T. T. Tang, “STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma,” Cancer Letters, vol. 325, pp. 80–88, 2012. View at Google Scholar
  9. H. Lee, J. Deng, M. Kujawski et al., “STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors,” Nature Medicine, vol. 16, no. 12, pp. 1421–1428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Deng, Y. Liu, H. Lee et al., “S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites,” Cancer Cell, vol. 21, pp. 642–654, 2012. View at Google Scholar
  11. W. de Lau, N. Barker, T. Y. Low et al., “Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling,” Nature, vol. 476, no. 7360, pp. 293–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Glinka, C. Dolde, N. Kirsch et al., “LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling,” EMBO Reports, vol. 12, no. 10, pp. 1055–1061, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Niehrs, “The complex world of WNT receptor signalling,” Nature Reviews Molecular Cell Biology, vol. 13, pp. 767–779, 2012. View at Google Scholar
  14. Y. Qian, S. Liu, Y. Guan et al., “Lgr4-mediated Wnt/β-catenin signaling in peritubular myoid cells is essential for spermatogenesis,” Development, vol. 140, pp. 1751–1761, 2013. View at Google Scholar
  15. J. Luo, W. Zhou, X. Zhou et al., “Regulation of bone formation and remodeling by G-protein-coupled receptor 48,” Development, vol. 136, no. 16, pp. 2747–2756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Mohri, S. Kato, A. Umezawa, R. Okuyama, and K. Nishimori, “Impaired hair placode formation with reduced expression of hair follicle-related genes in mice lacking Lgr4,” Developmental Dynamics, vol. 237, no. 8, pp. 2235–2242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Weng, J. Luo, X. Cheng et al., “Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 16, pp. 6081–6086, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Oyama, Y. Mohri, M. Sone, A. Nawa, and K. Nishimori, “Conditional knockout of Lgr4 leads to impaired ductal elongation and branching morphogenesis in mouse mammary glands,” Sexual Development, vol. 5, no. 4, pp. 205–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. X.-Y. Li, Y. Lu, H.-Y. Sun et al., “G protein-coupled receptor 48 upregulates estrogen receptor α expression via cAMP/PKA signaling in the male reproductive tract,” Development, vol. 137, no. 1, pp. 151–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Siwko, L. Lai, J. Weng, and M. Liu, “Lgr4 in ocular evelopment and glaucoma,” Journal of Ophthalmology, vol. 2013, Article ID 987494, 9 pages, 2013. View at Publisher · View at Google Scholar
  21. U. Styrkarsdottir, G. Thorleifsson, P. Sulem et al., “Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits,” Nature, vol. 497, pp. 517–520, 2013. View at Google Scholar
  22. Y. Gao, K. Kitagawa, Y. Hiramatsu et al., “Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis,” Cancer Research, vol. 66, no. 24, pp. 11623–11631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Wu, N. Xie, K. Xie et al., “GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer,” Carcinogenesis, vol. 34, no. 12, pp. 2861–2869, 2013. View at Publisher · View at Google Scholar
  24. B. Du, W. Luo, R. Li et al., “Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression,” The Journal of Biological Chemistry, vol. 288, pp. 15131–15141, 2013. View at Publisher · View at Google Scholar